EN-RAGE (extracellular newly identified receptor for advanced glycation end-products binding protein) and mortality of long-term hemodialysis patients: Aprospective observational cohort study

Clinical Biochemistry

Volumn 45, Issue 7-8, 2012, Pages 556-560

  Kalousová, Marta ^a   Kuběna, Aleš A ^a   Benáková, Hana ^a   Dusilová Sulková, Sylvie ^b   Tesař, Vladimír ^a   Zima, Tomáš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Biomarker; Cardiovascular; EN RAGE; Hemodialysis; Infection; Inflammation; Mortality; Risk; S100A12

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BINDING PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; EXTRACELLULAR NEWLY IDENTIFIED RECEPTOR FOR ADVANCED GLYCATION END PRODUCT BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INFECTION; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; UNIVARIATE ANALYSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INFECTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; S100 PROTEINS; TIME FACTORS;

EID: 84860166220     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.014     Document Type: Article

References (32)

1. Pietzsch J., Hoppmann S. Human S100A12: a novel key player in inflammation?. Amino Acids 2009, 36:381-389.
2. Guignard F., Mauel J., Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 1995, 309:395-401.
3. Hitomi J., Yamaguchi K., Kikuchi Y., Kimura T., Maruyama K., Nagasaki K. A novel calcium-binding protein in amniotic fluid, CAAF1: its molecular cloning and tissue distribution. J Cell Sci 1996, 109:805-815.
4. Hitomi J., Kimura T., Kusumi E., Nakagawa S., Kuwabara S., Hatakeyama K., Yamaguchi K. Novel S100 proteins in human esophageal epithelial cells: CAAF1 expression is associated with cell growth arrest. Arch Histol Cytol 1998, 61:163-178.
5. Yamamura T., Hitomi J., Nagasaki K., Suzuki M., Takahashi E., Saito S., et al. Human CAAF1 gene-molecular cloning, gene structure, and chromosome mapping. Biochem Biophys Res Commun 1996, 221:356-360.
6. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003, 60:540-551.
7. Moroz O.V., Antson A.A., Murshudov G.N., Maitland N.J., Dodson G.G., Wilson K.S., et al. The three-dimensional structure of human S100A12. Acta Crystallogr D Biol Crystallogr 2001, 57:20-29.
8. Moroz O.V., Antson A.A., Dodson E.J., Burrell H.J., Grist S.J., Lloyd R.M., et al. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr D Biol Crystallogr 2002, 58:407-413.
9. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. JLeukoc Biol 2007, 81:1-5.
10. Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., et al. Expression of the pro-inflammatoryprotein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003, 42:1383-1389.
11. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1995, 97:889-901.
12. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 2007, 7:711-724.
13. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998-15004.
14. Yang Z., Tao T., Raftery M.J., Youssef P., Di Girolamo N., Geczy C.L. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001, 69:986-994.
15. Hoppmann S., Steinbach J., Pietzsch J. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo. Int J Biochem Cell Biol 2010, 42:651-661.
16. Miranda L.P., Tao T., Jones A., Chernushevich I., Standing K.G., Geczy C.L., Alewood P.F. Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). FEBS Lett 2001, 488:85-90.
17. Moroz O.V., Dodson G.G., Wilson K.S., Lukanidin E., Bronstein I.B. Multiple structural states of S100A12: a key to its functional diversity. Microsc Res Tech 2003, 60:581-592.
18. Foell D., Frosch M., Sorg C., Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004, 344:37-51.
19. Shepherd C.E., Goyette J., Utter V., Rahimi F., Yang Z., Geczy C.L., Halliday G.M. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol Aging 2006, 27:1554-1563.
20. Mori Y., Kosaki A., Kishimoto N., Kimura T., Iida K., Fukui M., et al. Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol 2009, 29:18-24.
21. Gebhardt C., Riehl A., Durchdewald M., Németh J., Fürstenberger G., Müller-Decker K., et al. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008, 205:275-285.
22. Kalousová M., Kubena A.A., Kostírová M., Vinglerová M., Mestek O., Dusilová-Sulková S., et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis 2010, 56:513-521.
23. Machin D., Cheung Y.B., Parmar M.K.B. Survival analysis: a practical approach 2006, John Wiley & Sons, Ltd, Chichester, England. second ed.
24. Kalousová M, Benáková H, Kuběna AA, Dusilová-Sulková S, Tesař V, Zima T, Pregnancy-Associated Plasma Protein A (PAPP-A) as an Independent Mortality Predictor in Long-Term Hemodialysis Patients, Kidney. Blood Press Res 2012;35:192-201.
25. Zakiyanov O, Kalousova M, Kriha V, Zima T, Tesar V, Serum S100A12 (EN-RAGE) Levels in Patiens with Decreased Renal Function and Subclinical Chronic Inflammatory Disease, Kidney. Blood Press Res 2011;34:457-64.
26. Nakashima A., Carrero J.J., Qureshi A.R., Miyamoto T., Anderstam B., Bárány P., et al. Effectof circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:2213-2219.
27. Uchiyama-Tanaka Y., Mori Y., Kosaki A., Kimura T., Moriishi M., Kawanishi H., Matsubara H. Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease. Ther Apher Dial 2008, 12:28-32.
28. Kosaki A., Hasegawa T., Kimura T., Iida K., Hitomi J., Matsubara H., et al. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2004, 89:5423-5428.
29. Foell D., Wittkowski H., Hammerschmidt I., Wulffraat N., Schmeling H., Frosch M., et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004, 50:1286-1295.
30. Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853.
31. Shiotsu Y., Mori Y., Nishimura M., Sakoda C., Tokoro T., Hatta T., et al. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol 2011, 6:718-723.
32. Gawdzik J., Mathew L., Kim G., Puri T.S., Hofmann Bowman M.A. Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease. Am J Nephrol 2011, 33:250-259.